Epidemiology and clinical features of bloodstream infections in hematology wards: One year experience at the catholic blood and marrow transplantation center

Infection and Chemotherapy

Volumn 45, Issue 1, 2013, Pages 51-61

  Kwon, Jae Cheol ^a,c   Kim, Si Hyun ^b,c   Choi, Jae Ki ^c   Cho, Sung Yeon ^c   Park, Yeon Joon ^c   Park, Sun Hee ^c   Choi, Su Mi ^c   Lee, Dong Gun ^c   Choi, Jung Hyun ^c   Yoo, Jin Hong ^c  

^a National Health Insurance Corporation   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Bacteremia; Blood borne pathogens; Epidemiology; Fungemia; Hematology

Indexed keywords

C REACTIVE PROTEIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; FLUCONAZOLE; ISEPAMICIN; MICAFUNGIN; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIBIOTIC PROPHYLAXIS; APLASTIC ANEMIA; ARTICLE; BLOOD SAMPLING; BLOODSTREAM INFECTION; CANCER CHEMOTHERAPY; CANDIDA TROPICALIS; CLINICAL FEATURE; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; FUNGEMIA; HUMAN; INCIDENCE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; NEUTROPENIA; PROGNOSIS; RETROSPECTIVE STUDY; ROTHIA MUCILAGINOSA; SHOCK; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS; TRICHOSPORON ASAHII;

EID: 84879077679     PISSN: 20932340     EISSN: 20926448     Source Type: Journal    
DOI: 10.3947/ic.2013.45.1.51     Document Type: Article

References (34)

1. Cherif H, Kronvall G, Bjorkholm M, Kalin M. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J 2003;4:420-6.
2. Worth LJ, Slavin MA. Bloodstream infections in haematology: risks and new challenges for prevention. Blood Rev 2009;23:113-22.
3. Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 2004;39 (Suppl 1):S25-31.
4. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003;36:1103-10.
5. Jugo J, Kennedy R, Crowe MJ, Lamrock G, McClurg RB, Rooney PJ, Morris TC, Johnston PG. Trends in bacteraemia on the haematology and oncology units of a UK tertiary referral hospital. J Hosp Infect 2002;50:48-55.
6. Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC, Hsueh PR. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect 2010;138:1044-51.
7. Lee DG, Kim SH, Kim SY, Kim CJ, Park WB, Song YG, Choi JH. Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med 2011;26:220-52.
8. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999;29:490-4.
9. Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D, di Grazia C, Frassoni F, Bacigalupo A, Viscoli C. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 2009;15:47-53.
10. Wang FD, Lin ML, Liu CY. Bacteremia in patients with hematological malignancies. Chemotherapy 2005;51:147-53.
11. Oliveira AL, de Souza M, Carvalho-Dias VM, Ruiz MA, Silla L, Tanaka PY, Simões BP, Trabasso P, Seber A, Lotfi CJ, Zanichelli MA, Araujo VR, Godoy C, Maiolino A, Urakawa P, Cunha CA, de Souza CA, Pasquini R, Nucci M. Epidemiology of bacteremia and factors associated with multidrug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2007;39:775-81.
12. Park SH, Choi SM, Lee DG, Choi JH, Yoo JH, Lee JW, Min WS, Shin WS, Kim CC. Current trends of infectious complications following hematopoietic stem cell transplantation in a single center. J Korean Med Sci 2006;21:199-207.
13. Choi SM, Lee DG, Park YH, Kim YJ, Kim HJ, Lee S, Choi JH, Yoo JH, Kim DW, Lee JW, Min WS, Shin WS, Kim CC. Infections in patients with acute leukemia: comparison of induction chemotherapy group and reinduction chemotherapy group. Infect Chemother 2003;35:78-85.
14. Choi H, Yoo JH, Shin WS, Kim YR, Kang MW, Kim DW, Lee JW, Park JW, Kim CC, Kim DJ. The spectrum of infection in patients with acute leukemia. Korean J Med 1994;46:496-504.
15. González-Barca E, Fernández-Sevilla A, Carratalá J, Salar A, Peris J, Grañena A, Gudiol F. Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia. Eur J Clin Microbiol Infect Dis 1999;18:539-44.
16. Rókusz L, Liptay L. Infections of febrile neutropenic patients in malignant hematological diseases. Mil Med 2003;168:355-9.
17. Escande MC, Herbrecht R. Prospective study of bacteraemia in cancer patients. Results of a French multicentre study. Support Care Cancer 1998;6:273-80.
18. Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997;25:247-59.
19. Paul M, Soares-Weiser K, Leibovici L. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ 2003;326:1111.
20. Wang FD, Liu YM, Liu CY. Bacteremia in patients with hematologic malignancies. J Formos Med Assoc 1998;97:405-9.
21. Wang FD, Liu CY, Hsu HC, Gau JP, Chau WK, Haung ML, Ho CH. A comparative study of cefepime versus ceftazidime as empiric therapy of febrile episodes in neutropenic patients. Chemotherapy 1999;45:370-9.
22. Baskaran ND, Gan GG, Adeeba K, Sam IC. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia. Int J Infect Dis 2007;11:513-7.
23. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenemresistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53:60-7.
24. Hu F, Chen S, Xu X, Guo Y, Liu Y, Zhu D, Zhang Y. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China. J Med Microbiol 2012;61:132-6.
25. Zarfel G, Hoenigl M, Würstl B, Leitner E, Salzer HJ, Valentin T, Posch J, Krause R, Grisold AJ. Emergence of carbapenemresistant Enterobacteriaceae in Austria, 2001-2010. Clin Microbiol Infect 2011;17:E5-8.
26. Hoecker JL, Pickering LK, Groschel D, Kohl S. Streptococcus salivarius sepsis in children with malignancies. J Pediatr 1978;92:337-8.
27. Pizzo PA, Ladisch S, Witebsky FG. Alpha-hemolytic streptococci: clinical significance in the cancer patient. Med Pediatr Oncol 1978;4:367-70.
28. Shenep JL. Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrob Agents 2000;14:129-35.
29. Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 2002;34:1524-9.
30. Almyroudis NG, Fuller A, Jakubowski A, Sepkowitz K, Jaffe D, Small TN, Kiehn TE, Pamer E, Papanicolaou GA. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 2005;7:11-7.
31. Todeschini G, Tecchio C, Borghero C, D'Emilio A, Pegoraro E, de Lalla F, Benedetti P, Spolaore P, Pellizzer G. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies. J Infect 2006;53:266-73.
32. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad, II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 2011;52:e56-93.
33. Sancho S, Artero A, Zaragoza R, Camarena JJ, González R, Nogueira JM. Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients. Eur J Clin Microbiol Infect Dis 2012;31:1791-6.
34. Reuben AG, Musher DM, Hamill RJ, Broucke I. Polymicrobial bacteremia: clinical and microbiologic patterns. Rev Infect Dis 1989;11:161-83.